Effects of Renin-Angiotensin-Aldosterone Inhibitors on Early Outcomes of Hypertensive COVID-19 Patients: A Randomized Triple-Blind Clinical Trial.

Farhad NajmeddinMaedeh SolhjooHaleh AshrafMohammadreza SalehiFatemeh RasooliMorteza GhoghaeiAbbas SoleimaniMaryam Bahreini

Published in: American journal of hypertension (2021)

This randomized triple-blind multi-centric clinical trial did not show any deleterious effects of ACEi/ARB medications in hypertensive COVID-19 patients.

Keyphrases

clinical trial
double blind
phase ii
open label
phase iii
blood pressure
sars cov
angiotensin converting enzyme
angiotensin ii
placebo controlled
study protocol
type diabetes
skeletal muscle